1h Free Analyst Time
The transfection technologies market is forecasted to grow by USD 675.9 million during 2023-2028, accelerating at a CAGR of 9.66% during the forecast period. The report on the transfection technologies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for monoclonal antibodies, continued developments in transfection technologies by market vendors, and growing adoption of CRISPR/CAS9 gene editing technology.
The transfection technologies market is segmented as below:
By Type
- Viral-vector based transfection
- Physical transfection
- Biochemical based transfection
By End-user
- Pharmaceutical and biotechnology companies
- Contract research organizations
- Academic and research institutes
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the transfection technologies market covers the following areas:
- Transfection technologies market sizing
- Transfection technologies market forecast
- Transfection technologies market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global transfection technologies market: Altogen Biosystems, Bio RAD Laboratories Inc., Danaher Corp., F. Hoffmann La Roche Ltd., GENLANTIS, ibidi GmbH, Inovio Pharmaceuticals Inc., Kytopen Corp., Life Technologies India Pvt Ltd., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, Promega Corp., QIAGEN NV, RJH BIOSCIENCES, Sartorius AG, SignaGen Laboratories, STEMCELL Technologies Inc., Takara Holdings Inc., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increased use of dual-reporter assays and co-transfection experiments."
According to the report, one of the major drivers for this market is the rising demand for monoclonal antibodies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Altogen Biosystems
- Bio Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- GENLANTIS
- ibidi GmbH
- Inovio Pharmaceuticals Inc.
- Kytopen Corp.
- Life Technologies India Pvt Ltd.
- Lonza Group Ltd.
- MaxCyte Inc.
- Merck KGaA
- Mirus Bio LLC
- OZ Biosciences
- Promega Corp.
- QIAGEN NV
- RJH BIOSCIENCES
- Sartorius AG
- SignaGen Laboratories
- STEMCELL Technologies Inc.
- Takara Holdings Inc.
- Thermo Fisher Scientific Inc.
